ResearcherThomas Jefferson University HospitalNo recent work listed

Aileen Deng

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5087516445. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2021: 1 paper

Papers 1

Multi-agent neoadjuvant chemotherapy improves survival in early-stage pancreatic cancer: A National Cancer Database analysis. Co-author DOI 10.1016/j.ejca.2021.01.004 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Atrayee Basu Mallick · 1 shared paper, 2021 · strength 0.15
- Paper Multi-agent neoadjuvant chemotherapy improves survival in early-stage pancreatic cancer: A National Cancer Database ana… DOI 10.1016/j.ejca.2021.01.004 ↗
James A. Posey · 1 shared paper, 2021 · strength 0.15
- Paper Multi-agent neoadjuvant chemotherapy improves survival in early-stage pancreatic cancer: A National Cancer Database ana… DOI 10.1016/j.ejca.2021.01.004 ↗
Jordan Michael Winter · 1 shared paper, 2021 · strength 0.15
- Paper Multi-agent neoadjuvant chemotherapy improves survival in early-stage pancreatic cancer: A National Cancer Database ana… DOI 10.1016/j.ejca.2021.01.004 ↗
Steven J. Cohen · 1 shared paper, 2021 · strength 0.15
- Paper Multi-agent neoadjuvant chemotherapy improves survival in early-stage pancreatic cancer: A National Cancer Database ana… DOI 10.1016/j.ejca.2021.01.004 ↗
Charles J. Yeo · 1 shared paper, 2021 · strength 0.15
- Paper Multi-agent neoadjuvant chemotherapy improves survival in early-stage pancreatic cancer: A National Cancer Database ana… DOI 10.1016/j.ejca.2021.01.004 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.